Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- Optimal Method for Mydriasis in Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Optimal Method for Mydriasis in Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02909140).
- Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and Syringe: Complete Statistical AnalysisIndependent statistical analysis of Optimisation of Controlled Human Malaria Infection Using Sporozoites Administered by Needle and Syringe: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Optimization of a New Adaptive Intervention to Increase COVID-19 Testing: Complete Statistical AnalysisIndependent statistical analysis of Optimization of a New Adaptive Intervention to Increase COVID-19 Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04757298).
- OPTIMIZE-1Independent statistical analysis of A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: primary endpoint…
- OPTIMIZE-2Independent statistical analysis of A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Opthalmic Suspension Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery: primary…
- Optimizing Care for Patients With Dementia: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Care for Patients With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03442322).
- Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Optimizing HPV Vaccine Introduction in Shanghai, China: Complete Statistical AnalysisIndependent statistical analysis of Optimizing HPV Vaccine Introduction in Shanghai, China: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03972813).
- Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00428116).
- Optimizing Self-management COPD Treatment Through the American Lung Association Helpline: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Self-management COPD Treatment Through the American Lung Association Helpline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05106257).
- Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression: Complete Statistical AnalysisIndependent statistical analysis of Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- OPTIMUMIndependent statistical analysis of Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02425644).
- OpTIONIndependent statistical analysis of Optimal Treatment for Recurrent Clostridium Difficile: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02667418).
- OPTISCREEN-BIndependent statistical analysis of Application of HBV Rapid Tests as a Tool for Wide-Use Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oral Calcitriol With Ketoconazole in CRPC: Complete Statistical AnalysisIndependent statistical analysis of Oral Calcitriol With Ketoconazole in CRPC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03261336).
- Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN): Complete Statistical AnalysisIndependent statistical analysis of Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN): primary endpoint results, effect estimate with…
- Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD): Complete Statistical AnalysisIndependent statistical analysis of Oral Iron Versus Oral Iron Plus a Web-based Behavioral Intervention in Young Children (IRONCHILD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): Complete Statistical AnalysisIndependent statistical analysis of Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Oral OKT3 for the Treatment of Active Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Oral OKT3 for the Treatment of Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01287195).
- Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation: Complete Statistical AnalysisIndependent statistical analysis of Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Oral Paricalcitol in Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Oral Paricalcitol in Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00587158).
- Oral Pathology Asynchronous Telementoring Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Oral Pathology Asynchronous Telementoring Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04166214).
- Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of Oral Pregabalin as Preemptive Analgesia in Abdominal Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04495374).
- Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia: Complete Statistical AnalysisIndependent statistical analysis of Oral Progesterone and Low Dose Aspirin in the Prevention of Preeclampsia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women: Complete Statistical AnalysisIndependent statistical analysis of Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma: Complete Statistical AnalysisIndependent statistical analysis of Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00301418).
- Oral Testosterone for the Treatment of Hypogonadism: Complete Statistical AnalysisIndependent statistical analysis of Oral Testosterone for the Treatment of Hypogonadism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01717768).
- Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence: Complete Statistical AnalysisIndependent statistical analysis of Oral vs. Injectable Naltrexone for Hospitalized Veterans With Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01856712).
- ORANGEIndependent statistical analysis of Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03717935).
- ORBIT IIIndependent statistical analysis of Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ORCA-V1Independent statistical analysis of A Study of Cytisinicline for Vaping Cessation in Adult Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05431387).
- ORCHARRDIndependent statistical analysis of Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- ORIENT-1Independent statistical analysis of Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ORIGAMAIndependent statistical analysis of Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ORIGINALComplete statistical analysis of the ORIGINAL phase 3 trial comparing tenecteplase with alteplase in Chinese patients with stroke, including trial design, non-inferiority methodology, efficacy, safety, and interpretation.
- ORIONIndependent statistical analysis of EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ORKAIndependent statistical analysis of Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01866423).
- Orthostatic Hypotension Treatment on Rehab Unit: Complete Statistical AnalysisIndependent statistical analysis of Orthostatic Hypotension Treatment on Rehab Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030874).
- ORTHOVISC Shoulder Osteoarthritis Study: Complete Statistical AnalysisIndependent statistical analysis of ORTHOVISC Shoulder Osteoarthritis Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00436969).
- Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation: Complete Statistical AnalysisIndependent statistical analysis of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03414814).
- OSKIRA-Asia-1Independent statistical analysis of Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Oslo-CoMetIndependent statistical analysis of Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OSU Plate Waste Study: Complete Statistical AnalysisIndependent statistical analysis of OSU Plate Waste Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02790502).
- OTBB2Independent statistical analysis of Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- OTT15-04Independent statistical analysis of Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the…
- Otteroo Case Series: Complete Statistical AnalysisIndependent statistical analysis of Otteroo Case Series: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03502265).
- OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery: primary endpoint results, effect estimate…
- OU-SCC-PI-4GIndependent statistical analysis of PARP Inhibition for Gliomas (PI-4G or π4g): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05297864).